HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keon Wook Kang Selected Research

Drug Therapy (Chemotherapy)

10/2018Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma.
8/2015Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer.
2/2015Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.
4/2013Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
1/2013Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
1/2012Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.
1/2012Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.
12/2011Alternative medical treatment for radioiodine-refractory thyroid cancers.
10/2011Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
2/2011The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keon Wook Kang Research Topics

Disease

137Neoplasms (Cancer)
09/2022 - 01/2002
52Breast Neoplasms (Breast Cancer)
12/2019 - 10/2006
16Neoplasm Metastasis (Metastasis)
11/2021 - 10/2006
12Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 04/2010
10Hepatocellular Carcinoma (Hepatoma)
12/2021 - 06/2007
9Inflammation (Inflammations)
12/2021 - 10/2002
8Lung Neoplasms (Lung Cancer)
02/2022 - 01/2012
8Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2011
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2009
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2002
8Fibrosis (Cirrhosis)
07/2019 - 01/2002
8Hypoxia (Hypoxemia)
10/2012 - 06/2007
7Glioma (Gliomas)
10/2020 - 11/2010
7Carcinogenesis
01/2017 - 05/2002
5Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2022 - 12/2015
5Melanoma (Melanoma, Malignant)
01/2020 - 01/2007
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 09/2005
5Atherosclerosis
04/2014 - 08/2004
4Non-alcoholic Fatty Liver Disease
01/2021 - 01/2016
4Adenocarcinoma of Lung
08/2020 - 03/2013
3Alcoholic Fatty Liver
12/2021 - 01/2019
3Papillary Thyroid Cancer
12/2019 - 05/2014
3Triple Negative Breast Neoplasms
12/2019 - 10/2011
3Adenocarcinoma
11/2018 - 01/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 07/2011
3Lymphatic Metastasis
01/2018 - 02/2006
2Multiple Myeloma
09/2022 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
09/2022 - 11/2016
2Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2013

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
04/2022 - 02/2002
28Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 02/2006
21TamoxifenFDA LinkGeneric
12/2019 - 06/2007
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2011
12Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013 - 09/2008
10Pharmaceutical PreparationsIBA
10/2020 - 10/2002
9Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2012
8Estrogen ReceptorsIBA
12/2019 - 04/2008
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 05/2008
7Radioisotopes (Radionuclides)IBA
04/2022 - 08/2005
7EnzymesIBA
01/2019 - 05/2002
6AntigensIBA
01/2022 - 04/2017
6LigandsIBA
11/2021 - 08/2011
6ErbB Receptors (EGF Receptor)IBA
01/2021 - 05/2008
6Biological ProductsIBA
12/2019 - 05/2008
6Fluorine-18IBA
04/2017 - 06/2012
6AntioxidantsIBA
05/2016 - 08/2008
5AlbuminsIBA
12/2021 - 01/2019
5IodineIBA
01/2021 - 07/2011
5CytokinesIBA
01/2020 - 08/2004
5Small Interfering RNA (siRNA)IBA
01/2019 - 05/2008
5Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
06/2014 - 05/2008
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2012 - 05/2008
4Gefitinib (Iressa)FDA Link
01/2021 - 08/2015
4Cysteine (L-Cysteine)FDA Link
10/2020 - 02/2002
4Histone Deacetylase InhibitorsIBA
06/2020 - 04/2008
4Peptides (Polypeptides)IBA
01/2020 - 03/2007
4AcidsIBA
01/2020 - 01/2012
4Methionine (L-Methionine)FDA Link
01/2020 - 08/2011
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019 - 10/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2019 - 01/2002
4Messenger RNA (mRNA)IBA
11/2018 - 01/2010
4sodium-iodide symporter (sodium iodide symporter)IBA
01/2017 - 04/2010
4Antineoplastic Agents (Antineoplastics)IBA
04/2015 - 01/2008
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2011 - 01/2009
4NF-kappa B (NF-kB)IBA
10/2010 - 03/2009
4oltiprazIBA
04/2009 - 01/2002
4Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2007 - 05/2003
3Histone Deacetylases (Histone Deacetylase)IBA
09/2022 - 04/2008
3Somatostatin Receptors (Somatostatin Receptor)IBA
04/2022 - 12/2015
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2021 - 01/2016
32- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
12/2020 - 12/2012
3DNA (Deoxyribonucleic Acid)IBA
06/2020 - 11/2011
3EstersIBA
01/2020 - 01/2012
3Carrier Proteins (Binding Protein)IBA
01/2020 - 01/2019
3IntegrinsIBA
01/2020 - 07/2011
3RNA (Ribonucleic Acid)IBA
01/2020 - 12/2019
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2019 - 07/2010
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2019 - 12/2008
3Hydroxyproline (4 Hydroxyproline)IBA
07/2019 - 10/2002
3Interleukin-6 (Interleukin 6)IBA
07/2019 - 01/2007
3p38 Mitogen-Activated Protein KinasesIBA
03/2019 - 01/2007
3Tyrosine (L-Tyrosine)FDA Link
01/2017 - 12/2009
31,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
08/2016 - 02/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014 - 08/2004
3Dimethylnitrosamine (Nitrosodimethylamine)IBA
06/2014 - 01/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2013 - 11/2006
3ProstaglandinsIBA
07/2013 - 05/2006
3amurensin GIBA
12/2012 - 11/2010
3Transcription Factors (Transcription Factor)IBA
11/2010 - 09/2008
3CCAAT-Enhancer-Binding Protein-betaIBA
01/2010 - 06/2007
2CKD-581IBA
09/2022 - 06/2020
2Peptide Receptors (Peptide Receptor)IBA
04/2022 - 04/2020

Therapy/Procedure

27Therapeutics
04/2022 - 10/2006
16Drug Therapy (Chemotherapy)
10/2018 - 05/2007
8Neoadjuvant Therapy
01/2018 - 04/2010
5Immunotherapy
10/2021 - 03/2007
5Radiotherapy
04/2020 - 12/2011
4Liver Transplantation
11/2019 - 05/2009
3Precision Medicine
04/2020 - 06/2016
3Lymph Node Excision (Lymph Node Dissection)
08/2010 - 09/2005